{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01755",
      "entity_text" : "LB/LN-like alpha-syn pathology",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01703",
      "entity_text" : "alpha-syn mAb",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Immunoblot analyses on soluble and insoluble alpha-syn fractions after sequentially extracting neurons in 1% TX-100 followed by 2% SDS further support that alpha-syn mAb treatment reduced LB/LN like alpha-syn pathology.",
  "reading_complete" : "2020-08-09T06:22:10Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T06:20:02Z",
  "trigger" : "reduced",
  "evidence" : [ "alpha-syn mAb treatment reduced LB/LN-like alpha-syn pathology" ],
  "pmc_id" : "4410967",
  "score" : 0
}